Neil D. Palmisiano

Hematology | Oncology
925 Chestnut St Ste 420
Philadelphia, PA 19107

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

Journal: Leukemia
Published: May 05, 2026

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Journal: Leukemia & lymphoma
Published: April 09, 2026

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Journal: Blood
Published: March 18, 2026

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Journal: Blood cancer journal
Published: July 01, 2025

Transcription Factors GATA1/2 in Hematological Disorders.

Transcription Factors GATA1/2 in Hematological Disorders.

Journal: EJHaem
Published: May 15, 2025

A Review of CEBPA's Role in Hereditary Leukemia.

A Review of CEBPA's Role in Hereditary Leukemia.

Journal: EJHaem
Published: May 14, 2025

Lymphoma and leukemia occurring during pregnancy.

Lymphoma and leukemia occurring during pregnancy.

Journal: Seminars in perinatology
Published: March 15, 2025

Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives.

Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives.

Journal: Journal of adolescent and young adult oncology
Published: January 20, 2025

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.

Journal: Blood advances
Published: October 28, 2024

A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI.

A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 02, 2024

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.

Journal: EJHaem
Published: July 10, 2024

Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study.

Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study.

Journal: American journal of hematology
Published: March 19, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026